glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Living on the Edge: ROS
Living on the Edge: ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target PMC Frontiers Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy Glutathione in Ovarian Cancer: A Double Edged Sword Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance ScienceDirect
Pay in 4 interest-free payments of $6.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



